StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.55+0.18 (+4.12%)

Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –

Alvotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $586.32M, up 19.7% from the year before. The highest annual figure on record is $586.32M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$586.32M+19.7%
FY2024Dec 31, 2024$489.68M+435.6%
FY2023Dec 31, 2023$91.43M+10.1%
FY2022Dec 31, 2022$83.03M+125.8%
FY2021Dec 31, 2021$36.77M-44.8%
FY2020Dec 31, 2020$66.62M–

More Alvotech figures

See a number that looks wrong?